The first method, a candidate gene loss-of-function approach, involves the creation of genetically-modified animals deficient for a specific gene with subsequent induction of atherosclerosis either by crossing the mouse line of interest with ldlr−/− or apoE−/− mice or by using the atherosclerosis-inducing diet (Figure 1). The gene discussed is LDLR; the disease is atherosclerosis.